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Chronic use of alcohol is associated with structural and functional alterations in brain
areas that subserve cognitive processes. Of particular importance is the prefrontal
cortex (PFC) that is involved in higher order behaviors such as decision making, risk
assessment and judgment. Understanding the mechanisms that underlie alcohol’s effects
on PFC function is important for developing strategies to overcome the cognitive deficits
that may predispose individuals to relapse. Our previous studies showed that acutely
applied ethanol inhibits network activity in slices of prefrontal cortex and that exogenous
and endogenous cannabinoids modulate up-state dynamics. In the present study, we
examined the effects of repeated alcohol exposure on cannabinoid regulation of up-states
in slice cultures of the prefrontal cortex. Compared to controls, up-state duration, but
not amplitude was enhanced when measured 4 days after a 10 day ethanol exposure
(44mM ethanol; equivalent to 0.2% blood ethanol). Administration of the CB1 agonist WIN
55,212-2 enhanced the amplitude of up-states in control cultures but not in those treated
previously with ethanol. This lack of effect occurred in the absence of any noticeable
change in CB1 receptor protein expression. Chronic ethanol treatment and withdrawal
also blunted WIN’s inhibition of electrically evoked GABA IPSCs in layer II/III pyramidal
neurons but not those in layer V/VI. WIN inhibited the amplitude of spontaneous GABA
IPSCs in both layers and the magnitude of this effect was not altered by ethanol treatment.
However, in layer V/VI neurons, WIN’s effect on sIPSC frequency was greater in ethanol
treated cultures. WIN also inhibited electrically evoked NMDA EPSCs in both layer II/III and
V/VI neurons but this action was unaffected by ethanol treatment and withdrawal. Overall,
these results suggest that ethanol’s down-regulation of cannabinoid signaling results in
altered network activity in the prefrontal cortex.
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INTRODUCTION
Addictive disorders are associated with cognitive deficits that
often persist into abstinence and may arise from dysfunction of
the prefrontal cortex (PFC; Koob and Volkow, 2010; Lundqvist,
2010). Because of the PFC’s role in controlling drug-seeking
behaviors, the persistent disruption of PFC function by chronic
drug or alcohol exposure may contribute to relapse following
periods of withdrawal and abstinence (Lasseter et al., 2010).
Long-term heavy alcohol use such as that associated with alcohol
dependence produces structural changes to the PFC (Pfefferbaum
et al., 1992; Chanraud et al., 2007), but it is likely that changes in
physiological processes that result in reduced or aberrant corti-
cal function presage structural abnormalities. In support of this,
studies with human alcohol dependent patients have reported
correlated reductions in behavioral and physiological indices of
frontal cortical function including reduced power of the delta fre-
quency in EEG recordings (Kamarajan et al., 2004; Chen et al.,
2007).
In addition to cognitive deficits that can persist well into
abstinence, alcohol dependent patients often also experience
disruptions in sleep (Junghanns et al., 2009), and alcohol
dependent mice exhibit reduced sleep efficiency and time spent
in non-REM sleep (Veatch, 2006). One form of cortical net-
work activity that contributes to slow frequencies in the delta
band (0–1Hz) and predominates in deep-stage slow-wave sleep
is the slow-oscillation (Amzica and Steriade, 1998). This EEG
rhythm arises from the bi-stable membrane potential of cortical
neurons (Steriade et al., 1993a,b,c) that spontaneously oscillates
between a quiescent, hyperpolarized “down-state” and periods of
depolarization called “up-states” that are crowned with robust
synaptic activity and action potentials. The shift between up-
and down-states is a network event because the transitions into
and out of these phases are synchronized across large popula-
tions of neurons in the cortex (Sanchez-Vives and McCormick,
2000; Seamans et al., 2003;Woodward and Pava, 2009, 2012). This
large-scale network activation is generated through the effects of
mixed glutamatergic and GABAergic synaptic transmission with
glutamate-activated currents serving as a depolarizing force mod-
erated by GABA-mediated conductance that provides a clamp
near the Cl− reversal potential (≈−55mV). As a result, up-
states are dependent upon NMDA, AMPA, and GABAA currents,
and up-state parameters are significantly altered by inhibition of
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these receptors with selective antagonists (Seamans et al., 2003)
or abused drugs including ethanol (EtOH; Tu et al., 2007).
Although glutamate and GABA are essential for maintaining
membrane bi-stability and the slow oscillation, neuromodulators
that are associated with different aspects of cognitive function
can modify the expression of up-states. For instance, the endo-
cannabinoid (EC) system regulates up-states and non-REM sleep
(Pava et al., 2014), and numerous studies have reported sig-
nificant alteration in the function of the EC system following
chronic EtOH treatment (CET; Glaser et al., 2003). Specifically,
repeated exposure of mice to EtOH produces widespread alter-
ations in behavioral and physiological responses to a CB1 agonist
(Pava et al., 2012) and other studies report that chronic EtOH
treatment (CET) reduces CB1 expression and function in whole
brain (Basavarajappa et al., 1998; Basavarajappa and Hungund,
1999), hippocampus (Mitrirattanakul et al., 2007), and cortex
(Vinod et al., 2006). Additional studies with alcohol preferring
rats (Hansson et al., 2007) or mice with a genetic knockout of
fatty acid amide hydrolase (FAAH; Vinod et al., 2008) indicate
that the propensity to consume EtOH is correlated with high lev-
els of anandamide (AEA) and reduced expression of CB1 in the
PFC. These findings, combined with those discussed above, sug-
gest that altered EC signaling in the cortex may be one factor
that contributes to the frontal deficits often observed in alcohol
dependent individuals.
Given the modulatory effects of the EC system on up-states
and the perturbations in EC function following CET, the present
study examined whether CET disrupts EC modulation of neo-
cortical up-states. Using a novel PFC slice culture system that
generates spontaneous episodes of membrane bi-stability, we
show that the duration of up-states is increased following with-
drawal from CET. In addition, the ability of a CB1 agonist to alter
up-state parameters is reduced in CET exposed cultures and this
appears to be due to a reduction in CB1 function that is specific
to GABAergic synapses on layer II/III PNs. These findings demon-
strate that CET alters normal cortical network activity via reduced
signaling through CB1 receptors.
METHODS
MICE
All mouse pups used in this study were obtained from breeding
colonies maintained at the Medical University of South Carolina.
Breeding pairs of C57BL6/J mice were originally obtained from
the Jackson Laboratories (Bar Harbor, ME). Housing and treat-
ment of all animals used in this study conformed to the Guide
for the Care and Use of Laboratory Animals (National Research
Council Committee for the Update of the Guide for the Care
and Use of Laboratory Animals Institute for Laboratory Animal
Research and National Academies Press, 2011).
CORTICAL ORGANOTYPIC CULTURES
Slice cultures of neonatal mouse cerebral cortex were prepared
as previously described with some modifications (Tu et al.,
2007). Postnatal day 1–5 mouse pups were deeply anesthetized
by placing them in an ice water bath for at least 2min prior to
decapitation. Brains were extracted and immediately submerged
in ice-cold sterile-filtered HEPES-buffered, sucrose dissection
solution containing (in mM): 200 sucrose, 1.9 KCl, 6 MgCl2, 0.5
CaCl2, 10 glucose, 0.4 ascorbic acid, 25 HEPES, pH 7.3. Coronal
sections (400μm) containing the anterior cingulate (ACC), pre-
limbic and infralimbic regions of the prefrontal cortex were
prepared on a vibrating microtome under sterile conditions in a
biosafety hood equipped with laminar flow. Slices representing
the right and left hemispheres of each section were transferred
to Millicell-CM 0.4μm biopore membrane inserts in six-well
culture plates containing 1mL pre-incubated high-serum media.
This media contained 50% BME, 25% Earl’s balanced salt solu-
tion, 25% heat-inactivated horse serum (HIHS), 5.9mg/mL glu-
cose, 25mM HEPES, 100μg/mL streptomycin, and 0.235mM
Glutamax. Slices were arranged on the membranes so that their
dorsal surfaces were aligned and their medial surfaces were
touching.
Cultures were maintained in an incubator at 37◦C and a
5% CO2 atmosphere with partial media exchanges every 2–3
days. Beginning at 3 days in vitro (DIV), high-serum media was
replaced with media containing 5% HIHS. At 14DIV, culture
media was supplemented with 20μM5-fluoro-2-deoxyuridine to
prevent glial overgrowth. All recordings from cultures were made
after 14DIV to allow recovery from slicing and for the cortical
network to mature.
CHRONIC EtOH TREATMENT (CET)
Cultures were exposed to CET (44mM) or control (CNTRL;
no EtOH) conditions over 10 days in sealed vapor chambers as
previously described (Chandler et al., 1993; Carpenter-Hyland
et al., 2004). At 14DIV culture media was replaced with EtOH-
containingmedia, and culture plates were placed into Tupperware
chambers with an open plastic reservoir filled with 250mL
of 1% SDS/44mM EtOH solution. The chambers were gassed
with a mixture of 5% CO2 balanced with air before being
sealed and placed inside a culture incubator maintained at 37◦C.
CNTRL cultures were treated identically to CET cultures with
the exception that neither the culture media nor the reser-
voir contained EtOH. On the tenth day of treatment, CET and
CNTRL cultures were removed from the vapor chambers for a
full media exchange with non-EtOH containing media before
being placed back into the incubator. For immunoblots, some
cultures were scraped immediately into microcentrifuge tubes
upon removal from the vapor chambers to prevent them from
undergoing withdrawal. All other cultures underwent 4 days
of withdrawal prior to use in immunoblots or physiological
experiments.
WHOLE-CELL ELECTROPHYSIOLOGY
On the day of recording, cultures were removed from the incuba-
tor, and the membrane immediately surrounding the culture was
cut from the rest of the insert while taking care not to damage the
tissue. The culture was then submerged in a recording chamber
perfused at 2mL/min with ACSF containing (in mM): 125NaCl,
2.5 KCl, 1.25NaH2PO4, 1.3MgCl2, 2.0 CaCl2, 0.4 ascorbic acid,
10 glucose, 25NaHCO3, 0.05% bovine serum albumin and
continuously bubbled with carbogen gas (95% O2/5% CO2).
Bath temperature was maintained at 32.0 ± 0.5◦C using a
heated recording chamber and an in-line flow-through heater
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controlled by a thermistor-coupled TC-342B temperature con-
troller (Warner Instruments, Hampden, CT). For current-clamp
experiments, patch-pipettes (1.5 × 1.1mm; 1.8 – 3.5M) were
filled with internal recording solution containing (in mM): 130
K-gluconate, 10 KCl, 2MgCl2, 0.1 EGTA, 10HEPES, 2NaATP,
0.3NaGTP, pH 7.3. For voltage-clamp recordings, patch-pipettes
were filled with a solution containing (in mM): 140 CsCl,
2 MgCl2, 0.1 EGTA, 10 HEPES, 2 NaATP, 0.3 NaGTP, 5 QX-
314, pH 7.3. Whole-cell patch-clamp recordings were made from
visually identified pyramidal neurons (PN) in the region of cul-
tured cortex corresponding to the ACC. Neurons were imaged
using a Zeiss FS2 microscope (Oberkochen, Germany) equipped
with an infrared video camera and Dodt gradient contrast optics.
For all recordings, gigaohm seals were obtained in voltage-clamp
mode using an Axoclamp 700A amplifier (Molecular Devices,
Sunnyvale, CA). For current-clamp experiments, the amplifier
mode was switched following breakthrough. Pipette access resis-
tance (5–25M) was monitored throughout experiments and
cells showing a significant deviation in access resistance (>25%)
were not used for analysis. Square-wave electrical stimuli (0.1ms)
used to evoke up-states or post-synaptic currents (PSCs) were
generated by a stimulus isolation unit and delivered to the tissue
via a concentric bipolar electrode placed in the cortical tissue. For
current clamp recordings up-states were evoked with a 750μA
pulse delivered at 0.033Hz to the lateral aspect of the cortex, dis-
tal to the recording site. For voltage clamp recordings of evoked
PSCs, the stimuli (75–200μA) were delivered to cortical layer
II/III proximal to the recording electrode at 0.05Hz.
GABAA-mediated inhibitory PSCs (IPSCs) were recorded
from neurons held at −70mV in ACSF supplemented with
(R,S)-amino-5-phosphonovaleric acid (DL-APV; 100μM),
6,7-dinitroquinoxaline-2,3-dione (DNQX; 20μM), and (2S)-
3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydroxypropyl]
(phenylmethyl) phosphinic acid (CGP-55845; 1μM) to block
NMDA-, AMPA-, and GABAB- mediated responses, respectively.
NMDA-mediated excitatory PSCs (EPSCs) were recorded from
cells held at +40mV in ACSF supplemented with picrotoxin
(100μM) and DNQX. Recordings from AMPA-mediated EPSCs
are not reported because it was not possible to obtain monosy-
naptic responses from the organotypic cultures used in this
study. This is likely due to the highly ramified synaptic structure
of these cultures that allows for the generation of up-states.
Data for all experiments were acquired at 10 kHz and filtered at
4 kHz. The amplifier output was digitized by an ITC-16 interface
(Instrutech, Port Washington, NY) controlled by AxoGraphX
software (AxoGraph Scientific, Sydney, Australia) running on a
Macintosh G4 (Apple Inc., Cupertino, CA).
WESTERN BLOTS
Tissue from cultures was harvested for cell fractionation either
immediately following treatment or after a 4 day withdrawal.
Prior to scraping, cultures were washed three times to remove
excessmedia in an ice-coldHEPES-buffered sucrose solution con-
taining (in mM): 200 sucrose, 1.9 KCl, 6MgCl2, 0.5 CaCl2, 10
glucose, 0.4 ascorbic acid, 25 HEPES, pH 7.3 with KOH.
A crude membrane fraction was prepared and tissue sam-
ples were used for western blotting as previously described
(Mulholland and Chandler, 2010). After separation on NuPage
Novex gels (4–12% Bis-Tris; Invitrogen Corp., Carlsbad, CA)
protein was transferred to Immobilon-P PVDF membranes
(Millipore Corporation, Billerica, MA). Membranes were blocked
in 1% non-fat dry milk plus 5% BSA and incubated at 4◦C
overnight in a 1:500 dilution of the L15 anti-CB1 primary anti-
body (kindly provided by Dr. Ken Mackie, Indiana University,
Bloomington, IN). A horseradish peroxidase (HRP) conjugated
goat anti-rabbit secondary antibody was then added and bands
were detected using enhanced chemiluminescence (ECL). The
band corresponding to the molecular weight of CB1 (≈52 kDa)
was quantified using computer-assisted densitometry with ImageJ
v1.41 (National Institutes of Health, USA).
STATISTICAL ANALYSIS
Statistical analysis of data was performed using Prism 4
(GraphPad Software, San Diego, CA). Bonferroni post-hoc tests
were conducted for all analysis of variance (ANOVA) tests when
appropriate. For measures of PSC inhibition by WIN:
− 1 × %change = %Inhibition
= Baseline PSC − Post-WIN PSC
Baseline PSC
× 100%
For all analyses α = 0.05.
RESULTS
ENHANCED UP-STATE DURATION AND DECREASED SENSITIVITY TO
WIN FOLLOWING CET
To examine the effects of a 4 day withdrawal from CET on
network activity, recordings of evoked up-states were compared
between control and EtOH treated slice cultures of mouse PFC
(Figure 1). CET cultures recorded after withdrawal had signifi-
cantly longer up-states compared to controls [t-test, t(34) = 2.33,
p = 0.026]. However, neither the number of action potentials
during up-states [APs; spiking, t(44) = 0.36, p = 0.72] nor the
amplitude of up-states [t(45) = 0.50, p = 0.62] differed between
treatment groups. A similar enhancement of up-state duration
is observed in cultures prepared from CB1 KO mice (Pava
et al., 2014), and withdrawal from chronic EtOH administra-
tion alters patterns of slow-wave sleep (Veatch, 2006; Mukherjee
and Simasko, 2009) and CB1 protein expression in the rodent
brain (Basavarajappa et al., 1998; Mitrirattanakul et al., 2007;
Pava et al., 2012). In order to determine if CET also altered CB1
function, the effect of the CB1 agonist, WIN 55,212-2 (WIN;
1μM), on up-state parameters was examined in CET cultures
after 4 days of withdrawal (Figure 2A). As reported previously,
acute application of WIN increased up-state amplitude and spik-
ing (Pava et al., 2014), but in cultures that had undergone a 4 day
recovery from CET, the ability of WIN to increase up-state ampli-
tude [t-test, t(13) = 2.9, p = 0.013] and spiking [t(12) = 3.8, p =
0.0026] was significantly blunted compared to control treated cul-
tures. WIN failed to alter up-state duration in either treatment
group [t(13) = 1.7, p = 0.12] consistent with previous findings.
We hypothesized that the down-regulation of CB1 function could
arise from reduced CB1 protein and performed western blots
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FIGURE 1 | Up-state duration is increased in cultures after
withdrawal from chronic treatment with 44mM EtOH. Example
traces: black trace is a representative example of an up-state from a
control treated culture and gray trace is an example from a chronic
EtOH culture. Graphs show summary data of baseline measures of
up-state parameters in control and CET culture (N = 23–26). Horizontal
lines represent group means. Asterisks represent significant group
differences (p < 0.05).
FIGURE 2 | The effects of WIN are blunted in cultures chronically
treated with 44mM EtOH, without changes in CB1 protein expression.
(A) Left: representative traces of up-states recorded from layer V/VI PNs in
control and CET cultures under baseline conditions and after application of
the CB1 agonist WIN (1μM). (A) Right: summary data from the
experiments comparing the WIN-induced change in up-state parameters
between control and CET cultures. (B) Top: summary data for CB1
immunoblots expressed as optical density of 52 kDa band (N = 3–4). Bars
represent mean ± s.e.m. Asterisks represent significant group differences:
∗p < 0.05 and ∗∗p < 0.01.
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for CB1 on crude membrane fractions from CET and control
cultures at two time points following ethanol treatment (0 h
and 96 h; Figure 2B). Surprisingly, there was not an interac-
tion between withdrawal time and treatment [Two-Way ANOVA,
F(1, 9) = 2.2, p = 0.17], and there was no main effect of CET on
CB1 protein content [F(1, 9) = 0.44, p = 0.52]. These results sug-
gest that withdrawal from CET produces a down-regulation of
CB1 function without affecting overall CB1 expression.
CET PRODUCES LAYER SPECIFIC CHANGES IN WIN-INDUCED
DEPRESSION OF GABAergic IPSCs
Although levels of CB1 protein were not affected, withdrawal
from CET produced a deficit in WIN’s ability to enhance up-
state amplitude suggesting a functional down-regulation of CB1
signaling. CB1 receptors are expressed throughout the corti-
cal mantle, but results from our previous study showed that
CB1-mediated depression of GABAergic synaptic transmission
is more robust at layer II/III synapses compared to layer V/VI
(Pava et al., 2014). To test whether CET affects CB1 signaling
in a layer-specific fashion, the effects of WIN on evoked GABA
IPSCs were determined for layer II/III and layer V/VI PNs in
control and CET cultures. As shown in Figure 3A, there was a
significant interaction between treatment and response to WIN
for measure of eIPSC amplitude [Two-Way repeated measures
ANOVA, F(1, 23) = 7.96, p = 0.0097] and area [F(1, 23) = 5.36,
p = 0.030] in layer II/III PNs. Post-hoc tests revealed that WIN
reduced eIPSC amplitude [Bonferroni adjusted t-test, t(23) =
5.82, p < 0.0001] and area [t(23) = 4.76, p = 0.0002] in control
cultures but not in CET cultures [amplitude: t(23) = 1.99, p =
0.12; area: t(23) = 1.62, p = 0.24] indicating that CET produced
a functional down-regulation of CB1 signaling at GABAergic
terminals onto layer II/III PNs. In layer V/VI PNs, there was
FIGURE 3 | CB1-mediated inhibition of GABAergic synapses on layer II/III
PNs is blunted following CET. (A) The effect of WIN on evoked GABAA
IPSCs recorded from layer II/III and layer V/VI PNs in control and CET cultures
(N = 6–13). White bars represent baseline measures and gray bars represent
IPSCs recorded following a 10min application of WIN (1μM). The traces to
the right are representative examples from each of the four groups. Traces in
black are baseline, and the superimposed gray traces are from the same
neurons in the presence of WIN. (B) The percent inhibition of IPSCs by WIN
in layer II/III and layer V/VI neurons from CET and control cultures. White bars
represent control treated cultures and gray bars represent data from CET
cultures. Right panel shows eIPSC area for individual neurons before (closed
circles) and after (open circles) exposure to WIN. All data shown are mean ±
s.e.m. Significant interactions are denoted by section signs (§) and significant
post-hoc tests are indicated by asterisks (∗). For all symbols conferring
statistical significance: single symbol p < 0.05, double symbol p < 0.01, triple
symbol p < 0.001.
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a main effect of WIN to reduce eIPSC amplitude [Two-Way
repeated measures ANOVA, F(1, 12) = 19.18, p = 0.0009] that
was driven by reductions in IPSCs from both control [Bonferroni
adjusted t-test, t(12) = 2.64, p = 0.043] and CET [t(23) = 3.50,
p = 0.0087] cultures. Measures of eIPSC area in layer V/VI neu-
rons also displayed a WIN × Treatment interaction [Two-Way
repeated measures ANOVA, F(1, 12) = 4.78, p = 0.049], how-
ever, unlike results from layer II/III PNs, IPSCs in CET cultures
were significantly inhibited by WIN (Bonferroni adjusted t-test,
t(23) = 5.82, t(12) = 3.85, p = 0.0046]. Although WIN inhibited
IPSC area in 6 out of 8 neurons from control cultures (Figure 3,
inset), as a group, this inhibition was not statistically significant.
[t(12) = 1.10, p = 0.59].
To compare the effects of CET on WIN-induced inhibition of
GABAA IPSCs between cortical layers, the percent inhibition of
eIPSCs was calculated (Figure 3B). There was a significant inter-
action between cortical layer and treatment for measures of IPSC
amplitude (Two-Way ANOVA, F(1, 37) = 4.50, p = 0.041]. The
interaction was driven by a significant reduction inWIN-induced
inhibition of IPSCs following CET that was selective for layer
II/III PNs [Bonferroni adjusted t-test, t(37) = 2.86, p = 0.014]
and not layer V/VI PNs [t(37) = 0.43, p > 0.99]. A similar effect
was observed formeasures of eIPSC area where there was an inter-
action between treatment and cortical layer [Two-Way ANOVA,
F(1, 36) = 7.88, p = 0.0080]. Again the inhibition by WIN of eIP-
SCs on layer II/III PNs was blunted by CET [Bonferroni adjusted
t-test, t(36) = 2.74, p = 0.019], and there was no difference in
the response to WIN for eIPSCs recorded from layer V/VI cells
[t(36) = 1.45, p = 0.31]. These data demonstrate that there is a
functional down-regulation of CB1 at GABAergic synapses on
layer II/III PNs.
In the experiments with eIPSCs, the stimulus intensity was
adjusted for each cell to obtain an IPSC amplitude of approxi-
mately 300 pA. Because the intensity of the synaptic response was
experimenter defined, it is not possible to determine whether CET
alters basal IPSC parameters. To address this concern, record-
ings of spontaneous IPSCs (sIPSCs) were obtained before and
after applying WIN (1μM) to layer II/III and layer V/VI neu-
rons in CET and control cultures (Figure 4A). In layer II/III PNs,
there was a significant main effect of WIN to reduce sIPSC ampli-
tude [Two-Way repeated measures ANOVA, F(1, 20) = 20.91, p =
0.0002] that was due to reductions in sIPSC amplitude in both
control [Bonferroni adjusted t-test, t(20) = 3.76, p = 0.0025] and
CET cultures [t(20) = 2.71, p = 0.027]. In layer II/III PNs, nei-
ther WIN [Two-Way repeated measures ANOVA, F(1, 21) = 3.84
p = 0.064] nor CET [F(1, 21) = 1.91, p = 0.18] altered the inter-
event interval of sIPSCs. However, in layer V/VI PNs, there was
a main effect of CET to increase the IEI of sIPSCs [Two-Way
repeated measures ANOVA, F(1, 13) = 7.38, p = 0.018] suggest-
ing a down-regulation in basal GABAergic signaling in this layer
following CET. In addition, there was also a significant main
effect of WIN [F(1, 13) = 5.49, p = 0.036] to increase the IEI of
sIPSCs on layer V/VI PNs in CET cultures [Bonferroni adjusted
t-test, t(13) = 2.87, p = 0.027] but not controls [t(13) = 0.19, p >
0.99]. There was no effect of either CET [Two-Way repeated mea-
sures ANOVA, F(1, 15) = 2.62, p = 0.13] orWIN [F(1, 15) = 3.22,
p = 0.093] on sIPSC amplitude on layer V/VI PNs.
To directly compare changes in CB1-mediated signaling
between cortical layers, the percent change of sIPSC amplitude
and IEI were calculated (Figure 4B). There was no effect of
either cortical layer [Two-Way ANOVA, F(1, 36) = 0.78, p =
0.38] or CET [F(1, 36) = 0.25, p = 0.62] on CB1-mediated inhi-
bition of sIPSC amplitude. However, there was significant
interaction between cortical layer and treatment [Two-Way
ANOVA, F(1, 35) = 5.00, p = 0.032] and a main effect of cor-
tical layer [F(1, 35) = 11.53, p = 0.0017] on the IEI of sIPSCs.
FIGURE 4 | CB1-mediated inhibition of GABAergic sIPSCs onto layer
V/VI PNs is enhanced following CET. (A) The effect of WIN on
spontaneous GABAA IPSCs recorded from layer II/III and layer V/VI PNs in
control and CET cultures (N = 7–12). White bars represent baseline
measures and gray bars represent IPSCs recorded following a 10min
application of WIN (1μM). Traces in the middle of (A) are representative
examples from each of the four groups. The group of traces to the right is
from control cultures, and traces to the left are from CET cultures. The top
row of traces is from layer II/III PNs, and the bottom row is from layer V/VI.
Black traces represent baseline recordings, and the adjacent gray traces are
from the same neuron after a 10min WIN application. All data shown are
mean ± s.e.m. Symbols: †, main effect of EtOH treatment; ∗, significant
pair-wise comparison. (B) the percent change of sIPSCs from layer II/III and
layer V/VI neurons in control and CET cultures. All data shown are mean ±
s.e.m. Symbols: §, interaction; †, main effect of cortical layer; ∗, significant
post-hoc comparisons. For all symbols conferring statistical significance:
single symbol p < 0.05, double symbol p < 0.01.
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This interaction was due to a WIN-induced increase in the IEI
observed in layer V/VI PNs from CET cultures that was not
observed in layer V/VI PNs from control cultures [Bonferroni
adjusted t-test, t(35) = 2.42, p = 0.042] or layer II/III PNs from
CET cultures [t(35) = 3.81, p = 0.0011]. These data provide
further support for a gain of function for CB1 signaling at
GABAergic synapses onto layer V/VI synapses following CET.
CET DOES NOT ALTER CB1 SIGNALING AT GLUTAMATERGIC SYNAPSES
In addition to down-regulating CB1 at GABAergic terminals,
the blunted response of up-states in CET cultures to WIN
could be due to an up-regulation of CB1 at glutamate synapses
that helps to balance the disinhibition caused by activation of
CB1 at GABAergic terminals. At least one study has demon-
strated increased CB1 expression in the PFC of alcohol exposed
rodents suggesting this may be possible (Rimondini et al.,
2002). To explore this idea in the current study, NMDA EPSCs
were recorded from layer II/III and layer V/VI PNs in CET
and control cultures before and after the application of WIN
(1μM; Figure 5A). In layer II/III PNs, there was no effect of
CET on EPSC amplitude [Two-Way repeated measures ANOVA,
F(1, 15) = 0.99, p = 0.34] or area [F(1, 15) = 0.0031, p = 0.96],
but there was a main effect of WIN to reduce both EPSC
amplitude [F(1, 15) = 106.8, p < 0.0001] and area [F(1, 15) =
55.59, p < 0.0001]. WIN reduced EPSC amplitude in both con-
trol [Bonferroni adjusted t-test, t(15) = 8.053 p < 0.0001] and
CET cultures [t(15) = 6.61, p < 0.0001], and produced a similar
reduction in EPSC area in control [t(15) = 5.80, p < 0.0001] and
CET [t(15) = 4.78, p = 0.0005] cultures. These data indicate that
treatment with EtOH did not alter the sensitivity of glutamate ter-
minals on layer II/III neurons to WIN. Similar to the findings in
layer II/III neurons, there was no effect of CET on NMDA EPSCs
recorded from layer V/VI PNs for measures of either amplitude
[Two-Way repeatedmeasures ANOVAs, F(1, 17) = 2.12, p = 0.16]
or area [F(1, 16) = 3.18, p = 0.093], but there was a main effect of
WIN to reduce EPSC amplitude [F(1, 17) = 69, p < 0.0001] and
area [F(1, 16) = 26.13, p = 0.0001]. Pair-wise comparisons found
that WIN application significantly reduced EPSC amplitude
FIGURE 5 | CB1-mediated inhibition of glutamatergic transmission is not
altered by CET. (A) The effect of WIN on evoked NMDA EPSCs recorded
from layer II/III and layer V/VI PNs in control and CET cultures (N = 8–9).
White bars represent baseline measures and gray bars represent EPSCs
recorded following a 10min application of WIN (1μM). The traces to the right
are representative examples from each of the four groups. Traces in black are
baseline, and the superimposed gray traces are from the same neurons in
the presence of WIN. (B) The percent inhibition of EPSCs by WIN in layer II/III
and layer V/VI neurons from CET and control cultures. White bars represent
control treated cultures and gray bars represent data from CET cultures. All
data shown are mean ± s.e.m. Symbols: †, main effect of cortical layer; ∗,
significant pair-wise comparison. For all symbols conferring statistical
significance: single symbol p < 0.05, double symbol p < 0.01, triple symbol
p < 0.001.
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in both treatment groups [Bonferroni adjusted t-test, control:
t(17) = 5.58, CET: t(17) = 6.16, p < 0.0001], and similarly, WIN
reduced EPSC area in both control [t(16) = 4.52, p = 0.0007] and
CET cultures [t(16) = 2.71, p = 0.031]. The percent inhibition
of EPSCs by WIN was calculated and these values were com-
pared across cortical layers (Figure 5B). CET did not affect the
sensitivity of EPSC amplitude to inhibition by WIN [Two-Way
ANOVA, F(1, 32) = 1.01, p = 0.32], and there was no difference
in the amplitude of evoked NMDA EPSCs between cortical lay-
ers [F(1, 32) = 3.27, p = 0.080]. However, measurements of EPSC
area indicate that currents recorded from layer II/III were inhib-
ited to a greater extent that those recorded from layer V/VI
[main effect of cortical layer, two-way ANOVA, F(1, 32) = 7.51,
p = 0.0099], but again there was no effect of CET [F(1, 32) = 0.51,
p = 0.48]. These results show that CET does not alter CB1 sig-
naling at glutamatergic synapses onto layer II/III or layer V/VI
pyramidal neurons.
DISCUSSION
Chronic exposure to EtOH alters components of the EC system,
but few studies have examined the effect of EtOH on cannabinoid
receptor expression and function in the PFC. In the present inves-
tigation, organotypic cultures of mouse PFC were chronically
exposed to EtOH for 10 days and subsequently allowed to with-
draw for 4 days to examine persistent effects on network activity.
Reminiscent of findings from CB1 KO cultures (Pava et al., 2014),
up-state duration was significantly enhanced following with-
drawal from EtOH treatment, and despite no significant change
in CB1 protein expression, the response of up-states to WIN was
blunted at this time point. As the response of PSCs to WIN is
dependent on cortical layer and PSC type (i.e., glutamatergic or
GABAergic; Pava et al., 2014), experiments were performed to
determine if the reduction in CB1 signaling after CET showed
any layer selectivity (summarized in Figure 6). CET significantly
reduced the CB1-mediated inhibition of layer II/III GABAergic
transmission, and there was an increase in CB1-mediated inhibi-
tion of GABA IPSCs on layer V/VI neurons that was evident in
some measures but not others. Furthermore, CET did not alter
the sensitivity of NMDA EPSCs toWIN indicating that the effects
of CET on the up-state response to WIN are likely due to altered
CB1 signaling at GABAergic synapses. A caveat to this conclusion
is that, in this study, we did not examine a role for CB2 receptors
that are also activated by WIN and have been suggested to have
actions on cortical activity (Ortega-Alvaro et al., 2011). However,
as our previous findings show that the actions ofWIN on up-state
parameters are eliminated in PFC slice cultures prepared from
CB1 knockout mice (Pava et al., 2014), we feel that invoking a
CB2 mediated mechanism for any of the observed effects is not
warranted.
NETWORK ACTIVITY AND CB1 EXPRESSION AND FUNCTION ARE
DISRUPTED FOLLOWINGWITHDRAWAL FROM CET
Alcohol dependent patients display poor performance on PFC-
dependent tasks and this is correlated with reduced power of
delta frequency EEG measurements of frontal cortical function
(Kamarajan et al., 2004; Chen et al., 2007). In addition, the
sleep efficiency and time spent in slow-wave sleep are reduced
in rodent models of dependence (Veatch, 2006). Up-states are
the cellular correlate of the slow-oscillation that predominates
during deep-stage non-REM sleep (Amzica and Steriade, 1998)
and can be reconstituted in vitro using organotypic neocor-
tical cultures that are amenable to studies using highly con-
trolled chronic drug treatment (Seamans et al., 2003). In the
present work, up-state duration was longer in cultures exposed
to CET suggesting that EtOH treatment and withdrawal leads
to neuroadaptive changes that contribute to altered network
dynamics.
In our previous study, cultures with a chronic deficit of CB1
receptors (i.e., cultures prepared from CB1 KO mice) also dis-
played enhanced duration of up-states as compared towt cultures
(Pava et al., 2014), suggesting a role for the EC system in reg-
ulating cortical network activity. Studies in the hippocampus
have reported a down-regulation of CB1 following the induc-
tion of EtOH tolerance/dependence that rebounds above control
levels during withdrawal (Vinod et al., 2006; Mitrirattanakul
et al., 2007), and a study in the cortex found increased CB1
gene expression following a 3 week withdrawal from chronic
ethanol administration (Rimondini et al., 2002). It is important
to note that both of these investigations used in vivo regimens of
ethanol treatment and withdrawal that lasted many weeks. In the
present study, ethanol exposure and withdrawal was more lim-
ited due to the shorter lifespan of the in vitro cortical cultures.
Consequently, the data in the present study are consistent with
most findings in neocortical and hippocampal tissue in rodent
models of dependence, although they differ somewhat from those
of Vinod et al. (2006). The decrease in CB1 binding and cou-
pling in the cortex observed by Vinod et al occurred immediately
after removal of mice from 72 h of continuous treatment with
EtOH vapor, while in the present study, CB1 protein expression
in CET cultures were similar to control levels immediately fol-
lowing treatment. Furthermore, Vinod et al. (2006) report that
CB1 binding and G-protein coupling returned to control levels
following a 24 h withdrawal, but in the present work, CB1 protein
expression was unchanged relative to controls following a 4 day
withdrawal from CET despite a reduction in WIN-induced alter-
ation of up-state amplitude. These results suggest that EtOH may
induce differential effects on CB1 protein expression, G-protein
coupling efficiency, and perhaps cell surface expression that vary
across both brain regions and EtOH exposure patterns. Future
studies are needed to fully characterize the timecourse of fluctu-
ations in CB1 expression and function over the course of EtOH
treatment and withdrawal.
The mechanism behind EtOH’s modulation of CB1 is likely
to be due to alterations in the tone of EC transmitters in the
brain. Previous studies reporting a decrease in CB1 receptors
following EtOH treatment in rodents have found a correlated
increase in tissue levels of AEA (Vinod et al., 2006) and 2-AG
(Mitrirattanakul et al., 2007). Along these lines, alcohol preferring
rats exhibit reduced FAAH activity in the PFC that is correlated
with decreased CB1 function, and the alcohol preferring phe-
notype can be reconstituted in wistar rats by microinjecting a
FAAH inhibitor into the PFC (Hansson et al., 2007). Similarly,
FAAH KO mice exhibit enhanced EtOH preference compared
to wt mice and have reduced CB1 binding in the CA1 region
Frontiers in Integrative Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 58 | 8
Pava and Woodward Up-state modulation by ethanol and cannabinoids
FIGURE 6 | Model diagram summarizing the effects of CB1 activation
on specific synapses under basal conditions and following chronic
EtOH treatment. Under baseline conditions, CB1 activation reduces
GABAergic and NMDA receptor-mediated glutamate transmission at
synapses on layer II/III and layer V/VI PNs. The inhibition of GABAergic
transmission onto layer II/III PNs is much greater than at GABA synapses
on layer V/VI neurons. There is no difference in the inhibition of glutamate
transmission between layers. Following chronic EtOH treatment, the
CB1-mediated disinhibition of layer II/III PNs is reduced, and there is a gain
of function in CB1 signaling at deep-layer GABA synapses effectively
switching the cannabinoid sensitivity between cortical layers. Chronic EtOH
treatment does not affect CB1 signaling at glutamate synapses.
Abbreviations: CB1, cannabinoid receptor 1; CCK+, cholecystokinin
positive; Cl−, chloride ion, ECs, endocannabinoids; EPSP, excitatory
post-synaptic potential; GABA, γ-amino-butyric acid; IPSP, inhibitory
post-synaptic potential; Na+, sodium ion; WIN, WIN 55,212-2.
of the hippocampus (Vinod et al., 2008). These results demon-
strate that either pharmacologically induced EtOH dependence
or a genetic predisposition to consume EtOH is correlated with
enhanced AEA tone and decreased CB1 expression. However,
studies using chronic AEA administration in FAAH KO mice or
chronic administration of FAAH inhibitors to wt mice consis-
tently find no change in CB1 expression or agonist-stimulated
GTPγS binding (Falenski et al., 2010; Schlosburg et al., 2010,
2014). In contrast, these studies do observe reduced CB1 expres-
sion and G-protein coupling with chronic up-regulation of 2-AG
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following MAGL inhibition. Results reported in Pava et al. (2014)
suggest that EC tone is permissive for the generation of up-states
in the neocortex. As a consequence, it is possible that the alter-
ation in CB1 function observed in the present study is due to an
augmentation of EC tone, and future work should be directed at
determining the effect of chronic EtOH on EC tone and FAAH
and MAGL activity in the PFC.
REDUCED SENSITIVITY TO WIN IN CET CULTURES IS DUE TO A
REDUCTION IN CB1 SIGNALING AT GABAergic SYNAPSES ON LAYER
II/III PNs
As reported previously, the modulation of up-state parameters by
WIN was associated with a selective disinhibition of layer II/III
PNs (Pava et al., 2014). The results from this study complement
these findings by extending the work to include data from cul-
tures that have undergone withdrawal from chronic EtOH. In
humans, withdrawal from chronic EtOH is associated with a syn-
drome of enhanced CNS excitability (Saitz, 1998), and similar
observations have been made in rodent models where repeated
withdrawals from chronic EtOH enhance electrographic seizures
and handling-induced convulsions (Veatch and Becker, 2002). In
this study, CET displayed a blunted network response toWIN and
this was accompanied by a lack of sensitivity to the effects of WIN
on evoked GABAergic IPSCs onto layer II/III PNs.
Layer II/III PNs receive the majority of their inputs from dis-
tal regions of cortex, and in addition, they have a high degree of
intra-laminar connectivity compared to deep-layer PNs (Douglas
and Martin, 2004). A CB1-mediated reduction of GABAergic
input in layer II/III PNs is predicted to facilitate recruitment
of neurons that receive intra-laminar connections as well as
laver V/VI PNs that receive inputs from layer II/III. As a con-
sequence, the effects of CB1 activation at layer II/III GABA
terminals may synergize with the enhanced glutamatergic and
reduced GABAergic drive following CET that predisposes the
cortical network to increased excitability. Although measures of
network activity immediately following the removal of EtOH
were not made in this study, hippocampal explants demonstrate
seizure-like activity after the immediate cessation of long-term
EtOH treatment that is due to enhanced NMDA receptor acti-
vation (Hendricson et al., 2007). If similar conditions exist in
the PFC, then increased EC release would be expected, and
reduced CB1 function at layer II/III GABAergic synapses may
serve as a compensatory mechanism to reduce activity in the
network.
In contrast to the effects observed in layer II/III, the sensitivity
of eIPSCs in layer V/VI neurons to WIN was enhanced follow-
ing CET, indicating that the laminar distribution of CB1 function
at GABAergic synapses is reversed in CET cultures with respect
to controls. This result was surprising given the overall decreased
sensitivity of up-states to WIN following CET. Based upon the
present data, it is not clear if this enhancement represents up-
regulation of CB1 function, but if so, it seems likely that the
reduced function observed in layer II/III is overcomes this effect
with respect to network dynamics.
Layer V/VI PNs represent the major projection cells of the cor-
tex, and disinhibition of these neurons by cannabinoids would
increase the gain of cortical output. One consequence of increased
disinhibition of layer V/VI PNs would be to enhance excita-
tory drive in the cultures. CET cultures were found to display
longer up-states than controls, and this disinhibitory mechanism
may prolong up-state duration. However, CB1 KO cultures also
display prolonged up-states, so the functional consequences of
up-regulating the CB1-mediated disinhibition of layer V/VI PNs
are difficult to determine with the present dataset. Additionally,
the predicted effects of enhancing the disinhibition of deep-layer
PNs stand in contrast to studies suggesting decreased PFC func-
tion in addiction (Goldstein et al., 2004; Kamarajan et al., 2004;
Volkow et al., 2004). It is possible that the alteration to CB1
function may be in response to a reduction in EC tone due to
lower cellular activity, and along these lines, reduced EC tone is
predicted to facilitate an up-regulation of CB1 as the applica-
tion of CB1 antagonists is known to increase trafficking of this
receptor to the plasma membrane in cultured neurons (Leterrier
et al., 2006; Howlett et al., 2011). Consequently, the changes in
CB1-signaling in layer V/VI may arise from allostatic processes
characteristic of addiction (Koob and Le Moal, 2001).
A competing mechanism that could reduce sensitivity of up-
states to WIN would be an enhancement of CB1 function on glu-
tamatergic terminals thus reducing overall excitation. However,
WIN was equally effective in reducing EPSCs in EtOH treated
and control cultures suggesting that sensitivity was unaffected
by ethanol treatment. It is possible that at the concentration of
WIN (1μM) used for these experiments there was a ceiling effect
for NMDA EPSCs that obscured an ethanol-induced change in
cannabinoid sensitivity. However, this seems unlikely since this
same concentration ofWINwas also used in the studies recording
up-states, and if altered CB1 signaling at glutamate synapses were
responsible for the blunted effect on up-states then this should
be apparent in the recordings of NMDA EPSCs. Therefore, it
is unlikely that an increased sensitivity of excitatory synapses to
WINmediates the EtOH-induced changes in the cortical network
response to CB1 activation.
The findings from this study complement and extend those
from our previous report by demonstrating that chronic ethanol
exposure results in altered network activity in the PFC that is asso-
ciated with specific changes in the laminar distribution of CB1
signaling (Figure 6). These changes in the EC system likely result
from the increased excitability of the cortex that emerges dur-
ing withdrawal from CET, and they have potential ramifications
for cortical network activity. After the CNS excitability observed
during the acute phase of withdrawal subsides, alcohol depen-
dent patients often display cognitive deficits that are indicative
of reduced function of the prefrontal cortices. Decreased cortical
control of behaviors associated with drug-seeking is a hallmark
of addiction, and this state can persist into abstinence raising the
likelihood of relapse. Consequently, future studies in intact sys-
tems should be conducted to address whether the synapse-specific
alterations in CB1 signaling observed here contribute to reduced
cortical function associated with alcohol dependence.
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